A trial update for pramlintide was recorded on November 3, 2026. The study, titled "Outpatient Pramlintide Study," is listed under identifier NCT07914621. Its current status is not yet recruiting, meaning participant enrollment has not begun. The trial phase is listed as not applicable. No outcome data, results, or efficacy information have been reported for this study at this time. This update reflects only the registration and status information available as of the listed date. As the study has not started recruiting, further details such as enrollment criteria, timeline, or design specifics may be added as the listing is updated. Pramlintide is an approved compound, and this entry represents a new outpatient study involving its use. Readers interested in tracking this trial can refer to the official registry listing for the most current status. For more background on pramlintide, including its approved uses and general profile, readers can consult the compound overview.
Pramlintide Trial "Outpatient Pramlintide Study" Registered, Not Yet Recruiting
See the full pramlintide overview
Source: https://clinicaltrials.gov/study/NCT07914621